HOOKIPA PHARMA INC (HOOK)

US43906K1007 - Common Stock

0.712  -0.01 (-1.17%)

After market: 0.7222 +0.01 (+1.43%)

Fundamental Rating

4

Overall HOOK gets a fundamental rating of 4 out of 10. We evaluated HOOK against 592 industry peers in the Biotechnology industry. The financial health of HOOK is average, but there are quite some concerns on its profitability. HOOK shows excellent growth, but is valued quite expensive already.



1

1. Profitability

1.1 Basic Checks

In the past year HOOK has reported negative net income.
In the past year HOOK has reported a negative cash flow from operations.
In the past 5 years HOOK always reported negative net income.
HOOK had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

HOOK's Return On Assets of -50.57% is in line compared to the rest of the industry. HOOK outperforms 49.32% of its industry peers.
HOOK has a Return On Equity (-90.80%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -50.57%
ROE -90.8%
ROIC N/A
ROA(3y)-49.57%
ROA(5y)-40.42%
ROE(3y)-79.53%
ROE(5y)-60.66%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

HOOK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

HOOK does not have a ROIC to compare to the WACC, probably because it is not profitable.
HOOK has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, HOOK has more shares outstanding
HOOK has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -3.44, we must say that HOOK is in the distress zone and has some risk of bankruptcy.
HOOK has a Altman-Z score (-3.44) which is comparable to the rest of the industry.
There is no outstanding debt for HOOK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -3.44
ROIC/WACCN/A
WACC8.71%

2.3 Liquidity

HOOK has a Current Ratio of 3.50. This indicates that HOOK is financially healthy and has no problem in meeting its short term obligations.
HOOK's Current ratio of 3.50 is on the low side compared to the rest of the industry. HOOK is outperformed by 61.90% of its industry peers.
A Quick Ratio of 3.50 indicates that HOOK has no problem at all paying its short term obligations.
The Quick ratio of HOOK (3.50) is worse than 60.20% of its industry peers.
Industry RankSector Rank
Current Ratio 3.5
Quick Ratio 3.5

8

3. Growth

3.1 Past

HOOK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.67%, which is quite impressive.
The Revenue has grown by 41.21% in the past year. This is a very strong growth!
The Revenue has been growing by 21.41% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)26.67%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q35.29%
Revenue 1Y (TTM)41.21%
Revenue growth 3Y0.93%
Revenue growth 5Y21.41%
Revenue growth Q2Q-5.4%

3.2 Future

Based on estimates for the next years, HOOK will show a very strong growth in Earnings Per Share. The EPS will grow by 21.21% on average per year.
HOOK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 71.07% yearly.
EPS Next Y48.67%
EPS Next 2Y10.78%
EPS Next 3Y-3.76%
EPS Next 5Y21.21%
Revenue Next Year-10.1%
Revenue Next 2Y-16.03%
Revenue Next 3Y13.38%
Revenue Next 5Y71.07%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

0

4. Valuation

4.1 Price/Earnings Ratio

HOOK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year HOOK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

HOOK's earnings are expected to decrease with -3.76% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.78%
EPS Next 3Y-3.76%

0

5. Dividend

5.1 Amount

HOOK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HOOKIPA PHARMA INC

NASDAQ:HOOK (3/28/2024, 8:15:50 PM)

After market: 0.7222 +0.01 (+1.43%)

0.712

-0.01 (-1.17%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap70.45M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -50.57%
ROE -90.8%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.5
Quick Ratio 3.5
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)26.67%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y48.67%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)41.21%
Revenue growth 3Y0.93%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y